NCT00040144 - Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

May 31, 2003

Conditions

Chronic Hepatitis B

Interventions

DRUG

ACH126, 433

Trial Locations (18)

10021

Clinical Trial Site, New York

22031

Clinical Trial Site, Fairfax

33136

Clinical Trial Site, Miami

60612

Clinical Trial Site, Chicago

60637

Clinical Trial Site, Chicago

75246

Clinical Trial Site, Dallas

75390

Clinical Trial Site, Dallas

90048

Clinical Trial Site, Los Angeles

91105

Clinical Trial Site, Pasadena

92868

Clinical Trial Site, Orange

94143

Clinical Trial Site, San Francisco

98195

Clinical Trial Site, Seattle

02215

Clinical Trial Site, Boston

V5Z 1L5

Clinical Trial Site, Vancouver

M5G 2C4

Clinical Trial Site, Toronto

M5T 2S8

Clinical Trial Site, Toronto

H2X 3J4

Clinical Trial Site, Montreal

Unknown

Clinical Trial Site, Hong Kong